首页 > 最新文献

Experimental hematology最新文献

英文 中文
FT-4202, a selective pyruvate kinase R activator for sickle cell disease. 治疗镰状细胞病的选择性丙酮酸激酶 R 激活剂 FT-4202。
IF 2.5 4区 医学 Q2 HEMATOLOGY Pub Date : 2024-11-14 DOI: 10.1016/j.exphem.2024.104673
Anna Ericsson, David J Richard, Erik Wilker, Jr David R Lancia, Shawn Fessler, Paul Troccolo, Xiaozhang Zheng, Angela Toms, Christopher Dinsmore, Lili Yao, Frans A Kuypers, Sandra Larkin, Douglas Marcotte, Keertik Fulzele, Maria Ribadeneira, Sylvie M Guichard, Gary Marshall

Anemia in patients with sickle cell disease (SCD) increases 2,3-diphosphoglycerate (2,3-DPG), decreasing hemoglobin-oxygen (Hb-O2) affinity to improve oxygen offloading and promote hemoglobin polymerization (sickling) of red blood cells (RBCs). We report the discovery of FT-4202, an investigational, selective pyruvate kinase type-R (PKR) activator with a multimodal mechanism of action and potential to increase ATP and decrease 2,3-DPG, resulting in increased Hb-O2 affinity, decreased Hb polymerization, and improved RBC health. FT-4202 was identified via structure-enabled lead optimization medicinal chemistry using X-ray crystallography, molecular modeling, and thermal shift assays. FT-4202, an allosteric PKR activator, stabilizes the tetrameric enzyme and increases PKR activity in human and mouse RBCs in vitro. Seven-day oral administration of FT-4202 in Berkeley SCD mice reduced 2,3-DPG, increased Hb-O2 affinity, and reduced RBC sickling versus control. There were no adverse in vitro safety findings. FT-4202 offers a therapeutic opportunity to modify the course of SCD.

镰状细胞病(SCD)患者贫血会增加 2,3-二磷酸甘油酯(2,3-DPG),降低血红蛋白与氧(Hb-O2)的亲和力,从而改善氧负荷并促进红细胞(RBC)的血红蛋白聚合(镰状细胞)。我们报告发现了 FT-4202,它是一种研究性、选择性丙酮酸激酶-R 型(PKR)激活剂,具有多模式作用机制,可增加 ATP 和减少 2,3-DPG,从而增加 Hb-O2 亲和力、减少 Hb 聚合和改善红细胞健康。FT-4202 是利用 X 射线晶体学、分子建模和热位移测定法,通过结构先导优化药物化学鉴定出来的。FT-4202 是一种异位 PKR 激活剂,它能稳定四聚体酶并提高体外人和小鼠红细胞中 PKR 的活性。与对照组相比,伯克利SCD小鼠口服FT-4202七天可降低2,3-DPG,增加Hb-O2亲和力,并减少红细胞镰状病变。体外安全性方面没有发现任何不良反应。FT-4202 为改变 SCD 病程提供了治疗机会。
{"title":"FT-4202, a selective pyruvate kinase R activator for sickle cell disease.","authors":"Anna Ericsson, David J Richard, Erik Wilker, Jr David R Lancia, Shawn Fessler, Paul Troccolo, Xiaozhang Zheng, Angela Toms, Christopher Dinsmore, Lili Yao, Frans A Kuypers, Sandra Larkin, Douglas Marcotte, Keertik Fulzele, Maria Ribadeneira, Sylvie M Guichard, Gary Marshall","doi":"10.1016/j.exphem.2024.104673","DOIUrl":"https://doi.org/10.1016/j.exphem.2024.104673","url":null,"abstract":"<p><p>Anemia in patients with sickle cell disease (SCD) increases 2,3-diphosphoglycerate (2,3-DPG), decreasing hemoglobin-oxygen (Hb-O<sub>2</sub>) affinity to improve oxygen offloading and promote hemoglobin polymerization (sickling) of red blood cells (RBCs). We report the discovery of FT-4202, an investigational, selective pyruvate kinase type-R (PKR) activator with a multimodal mechanism of action and potential to increase ATP and decrease 2,3-DPG, resulting in increased Hb-O<sub>2</sub> affinity, decreased Hb polymerization, and improved RBC health. FT-4202 was identified via structure-enabled lead optimization medicinal chemistry using X-ray crystallography, molecular modeling, and thermal shift assays. FT-4202, an allosteric PKR activator, stabilizes the tetrameric enzyme and increases PKR activity in human and mouse RBCs in vitro. Seven-day oral administration of FT-4202 in Berkeley SCD mice reduced 2,3-DPG, increased Hb-O<sub>2</sub> affinity, and reduced RBC sickling versus control. There were no adverse in vitro safety findings. FT-4202 offers a therapeutic opportunity to modify the course of SCD.</p>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":" ","pages":"104673"},"PeriodicalIF":2.5,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142644307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Structural diversity and function of the granulocyte colony-stimulating factor in medaka fish. 青鳉体内粒细胞集落刺激因子的结构多样性与功能
IF 2.5 4区 医学 Q2 HEMATOLOGY Pub Date : 2024-11-13 DOI: 10.1016/j.exphem.2024.104672
Ayame Ogawa, Shungo Konno, Satoshi Ansai, Kiyoshi Naruse, Takashi Kato

Diversity in the granulocyte repertoire, including neutrophils, basophils, and eosinophils, has been reported in vertebrate species. Medaka fish (Oryzias latipes) have only neutrophils; however, the storage pool of granulopoiesis tissues and the molecular mechanism of granulopoiesis in medaka fish have not been explored. Granulocyte colony-stimulating factor (G-CSF) is a cytokine responsible for neutrophil differentiation, survival, and proliferation. We performed in silico analysis to molecularly characterize the medaka G-CSF and G-CSF receptor (G-CSFR) genes. This study showed that medaka G-CSF differs considerably from human and mouse G-CSF in terms of the primary protein structure; however, the predicted tertiary structure was largely conserved. Analyses of lipopolysaccharide stimulation and G-CSF knockout and overexpression in medaka revealed that G-CSF mobilizes neutrophils into the peripheral blood. The analysis of G-CSF-deficient medaka revealed that G-CSF is involved in erythropoiesis. These findings represent an important first step toward understanding granulocyte hematopoiesis in non-mammalian species.

据报道,脊椎动物中的粒细胞具有多样性,包括中性粒细胞、嗜碱性粒细胞和嗜酸性粒细胞。青鳉鱼(Oryzias latipes)只有中性粒细胞;然而,青鳉鱼中粒细胞生成组织的储存库和粒细胞生成的分子机制尚未得到探索。粒细胞集落刺激因子(G-CSF)是一种细胞因子,负责中性粒细胞的分化、存活和增殖。我们对青鳉的 G-CSF 和 G-CSF 受体(G-CSFR)基因进行了分子分析。研究结果表明,青鳉 G-CSF 与人类和小鼠 G-CSF 的一级蛋白结构有很大不同,但预测的三级结构基本保持一致。对脂多糖刺激和青鳉体内 G-CSF 基因敲除和过表达的分析表明,G-CSF 能动员中性粒细胞进入外周血。对 G-CSF 缺陷青鳉的分析表明,G-CSF 参与红细胞生成。这些发现为了解非哺乳动物的粒细胞造血迈出了重要的第一步。
{"title":"Structural diversity and function of the granulocyte colony-stimulating factor in medaka fish.","authors":"Ayame Ogawa, Shungo Konno, Satoshi Ansai, Kiyoshi Naruse, Takashi Kato","doi":"10.1016/j.exphem.2024.104672","DOIUrl":"https://doi.org/10.1016/j.exphem.2024.104672","url":null,"abstract":"<p><p>Diversity in the granulocyte repertoire, including neutrophils, basophils, and eosinophils, has been reported in vertebrate species. Medaka fish (Oryzias latipes) have only neutrophils; however, the storage pool of granulopoiesis tissues and the molecular mechanism of granulopoiesis in medaka fish have not been explored. Granulocyte colony-stimulating factor (G-CSF) is a cytokine responsible for neutrophil differentiation, survival, and proliferation. We performed in silico analysis to molecularly characterize the medaka G-CSF and G-CSF receptor (G-CSFR) genes. This study showed that medaka G-CSF differs considerably from human and mouse G-CSF in terms of the primary protein structure; however, the predicted tertiary structure was largely conserved. Analyses of lipopolysaccharide stimulation and G-CSF knockout and overexpression in medaka revealed that G-CSF mobilizes neutrophils into the peripheral blood. The analysis of G-CSF-deficient medaka revealed that G-CSF is involved in erythropoiesis. These findings represent an important first step toward understanding granulocyte hematopoiesis in non-mammalian species.</p>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":" ","pages":"104672"},"PeriodicalIF":2.5,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142638408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Platelet ultrastructural changes stored at room temperature versus cold storage observed by electron microscopy and structured illumination microscopy. 用电子显微镜和结构照明显微镜观察血小板在室温储存与低温储存下的超微结构变化。
IF 2.5 4区 医学 Q2 HEMATOLOGY Pub Date : 2024-11-07 DOI: 10.1016/j.exphem.2024.104671
Yang Sun, Shunli Gu, Yan Ma, Aowei Song, Lili Xing, Jiameng Niu, Ru Yang, Xiaoyu Hu, Wenhua Wang, Ting Ma, Fenfang Tian, Liqin Wang, Xinxin Xie, Xiaofeng Huang, Wen Yin, Jiangcun Yang

Our study seeks to provide a theoretical foundation for the clinical use of Cold-stored platelets (CSPs) by interpreting ultrastructural images and quantitatively analyzing structural changes. CSPs, room temperature-stored platelets (RTPs), and delayed cold stored platelets(Delayed-CSPs) were continuously observed using scanning electron microscopy and transmission electron microscopy at 8 time points. Super-resolution fluorescence microscopy was employed to observe changes in platelet microtubules and mitochondrial structure and function, while platelet counts, metabolism, and relevant functional indicators were measured concurrently. Quantitative statistical analysis of platelet size, morphology, canalicular systems, and five organelles was performed under electron microscopy. CSPs stored for 1 day, platelet shape changed from circular or elliptical to spherical, with size decreasing from 2.8 × 2.2µm to 2.0 × 2.0µm. CSPs occurred wrinkling and reorganization of platelet microtubule proteins, with organelles aggregating towards the central region. CSPs stored for 14 days and Delayed-CSPs for 10 days exhibited numerous structurally intact and active cells. The structure-intact active cells in both group were 92% . RTPs stored for 5 and 7 days showed minimal changes in size, a normal microtubule skeleton, and were primarily in a resting state. However, RTPs stored for 10 and 14 days displayed swelling, irregular disintegration of the microtubule skeleton, and the presence of membranous structures and vacuolated cells,the structure-intact active cells was only 45% and 7%, respectively. Our findings confirmed that the maximum storage time of platelets was 5-7 days for RTPs, within 10 days for Delayed-CSPs, and 14 days for CSPs.

我们的研究旨在通过解读超微结构图像和定量分析结构变化,为冷藏血小板(CSP)的临床应用提供理论依据。研究使用扫描电子显微镜和透射电子显微镜连续观察了 8 个时间点的 CSP、室温储存血小板(RTP)和延迟冷藏血小板(Delayed-CSP)。采用超分辨率荧光显微镜观察血小板微管和线粒体结构与功能的变化,同时测量血小板数量、代谢和相关功能指标。在电子显微镜下对血小板的大小、形态、管腔系统和五个细胞器进行了定量统计分析。储存1天的CSP,血小板形状从圆形或椭圆形变为球形,大小从2.8×2.2µm减小到2.0×2.0µm。CSP 出现皱褶和血小板微管蛋白重组,细胞器向中心区域聚集。保存 14 天的 CSP 和保存 10 天的延迟 CSP 表现出大量结构完整的活性细胞。两组中结构完整的活性细胞均为 92%。储存 5 天和 7 天的 RTP 大小变化极小,微管骨架正常,主要处于静止状态。然而,储存 10 天和 14 天的 RTP 则出现肿胀、微管骨架不规则解体、膜状结构和空泡化细胞的存在,结构完好的活性细胞分别仅占 45% 和 7%。我们的研究结果证实,RTPs 的血小板最长储存时间为 5-7 天,Delayed-CSPs 为 10 天以内,CSPs 为 14 天。
{"title":"Platelet ultrastructural changes stored at room temperature versus cold storage observed by electron microscopy and structured illumination microscopy.","authors":"Yang Sun, Shunli Gu, Yan Ma, Aowei Song, Lili Xing, Jiameng Niu, Ru Yang, Xiaoyu Hu, Wenhua Wang, Ting Ma, Fenfang Tian, Liqin Wang, Xinxin Xie, Xiaofeng Huang, Wen Yin, Jiangcun Yang","doi":"10.1016/j.exphem.2024.104671","DOIUrl":"https://doi.org/10.1016/j.exphem.2024.104671","url":null,"abstract":"<p><p>Our study seeks to provide a theoretical foundation for the clinical use of Cold-stored platelets (CSPs) by interpreting ultrastructural images and quantitatively analyzing structural changes. CSPs, room temperature-stored platelets (RTPs), and delayed cold stored platelets(Delayed-CSPs) were continuously observed using scanning electron microscopy and transmission electron microscopy at 8 time points. Super-resolution fluorescence microscopy was employed to observe changes in platelet microtubules and mitochondrial structure and function, while platelet counts, metabolism, and relevant functional indicators were measured concurrently. Quantitative statistical analysis of platelet size, morphology, canalicular systems, and five organelles was performed under electron microscopy. CSPs stored for 1 day, platelet shape changed from circular or elliptical to spherical, with size decreasing from 2.8 × 2.2µm to 2.0 × 2.0µm. CSPs occurred wrinkling and reorganization of platelet microtubule proteins, with organelles aggregating towards the central region. CSPs stored for 14 days and Delayed-CSPs for 10 days exhibited numerous structurally intact and active cells. The structure-intact active cells in both group were 92% . RTPs stored for 5 and 7 days showed minimal changes in size, a normal microtubule skeleton, and were primarily in a resting state. However, RTPs stored for 10 and 14 days displayed swelling, irregular disintegration of the microtubule skeleton, and the presence of membranous structures and vacuolated cells,the structure-intact active cells was only 45% and 7%, respectively. Our findings confirmed that the maximum storage time of platelets was 5-7 days for RTPs, within 10 days for Delayed-CSPs, and 14 days for CSPs.</p>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":" ","pages":"104671"},"PeriodicalIF":2.5,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142617211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of avatrombopag in combination with standard immunosuppressive therapy for severe aplastic anemia 阿伐曲波帕与标准免疫抑制疗法联合治疗重型再生障碍性贫血的有效性和安全性
IF 2.5 4区 医学 Q2 HEMATOLOGY Pub Date : 2024-11-05 DOI: 10.1016/j.exphem.2024.104670
Jianping Li , Weiru Liang , Huihui Fan , Kang Zhou , Yuan Li , Wenrui Yang , Liping Jing , Li Zhang , Lei Ye , Youzhen Xiong , Guangxin Peng , Yang Yang , Weiping Yuan , Jun Shi , Fengkui Zhang , Xin Zhao
Severe aplastic anemia (SAA) is a life-threatening bone marrow failure disease. The addition of eltrombopag to immunosuppressive therapy (IST) improves the response rate, but its hepatotoxicity is concerning. Avatrombopag (AVA), a small-molecule thrombopoietin-receptor agonist without hepatotoxicity, has unknown efficacy in SAA treatment. This retrospective study assessed the efficacy and safety of AVA added to IST 42 SAA patients compared to a historical cohort of 84 patients receiving IST alone, using propensity score matching. The median age was 31.5 (6.0–67.0 years) years old in group A and 26 (16.0–45.0 years) years old in group B. At 3 months, group A showed higher complete response (CR) and overall response (OR) rates than group B (CR: 19.0% vs. 4.8%, p = 0.024; OR: 54.8% vs. 39.3%, p = 0.145). Higher CR and OR rates were also found at 6 months in group A than in group B (CR: 31.0% vs. 14.3%, p = 0.145; OR 71.4% vs. 51.2%, p = 0.048). In multivariate analysis of group A, a shorter interval from disease onset to antithymocyte globulin (ATG) treatment (≤6 months) (p = 0.005) predicted better responses rate at 6 months. Event-free survival was also improved in group A (60.7% vs. 49.6%). AVA was well-tolerated, with no hepatic injury observed during treatment, even in those with pre-existing hepatic impairment. The addition of AVA to IST improves both the response rate and response quality in patients with SAA while ensuring safety.
重型再生障碍性贫血(SAA)是一种危及生命的骨髓衰竭疾病。在免疫抑制疗法(IST)中加入艾曲波帕能提高再生障碍性贫血的应答率和应答质量,但其肝毒性令人担忧。阿瓦曲波帕(AVA)是另一种无肝脏毒性的小分子血小板生成素受体激动剂,但其在 SAA 治疗中的疗效尚不清楚。这项回顾性研究旨在评估小分子血小板生成素受体激动剂 AVA 加入 IST 治疗 SAA 患者的疗效和安全性。研究利用倾向评分匹配法,将接受 IST 和 AVA 治疗的 42 例患者与单独接受 IST 治疗的 84 例患者进行了比较。3 个月后,A 组的完全应答率(CR)和总应答率(OR)高于 B 组(CR:19.0% 对 4.8%,P=0.024;OR:54.8% 对 39.3%,P=0.145)。6 个月时,A 组的 CR 和 OR 率也高于 B 组(CR:31.0% 对 14.3%,P=0.145;OR:71.4% 对 51.2%,P=0.048)。在对A组的多变量分析中,从发病到接受抗胸腺细胞球蛋白(ATG)治疗的时间间隔越短(≤6个月)(P=0.005),6个月时的应答率就越高。A组的无事件生存率也有所提高(60.7% 对 49.6%)。AVA 的耐受性良好,在治疗过程中未观察到肝损伤,即使是那些原本就存在肝损伤的患者也是如此。在 IST 中加入 AVA 可提高 SAA 患者的应答率和应答质量,同时确保安全性。
{"title":"Efficacy and safety of avatrombopag in combination with standard immunosuppressive therapy for severe aplastic anemia","authors":"Jianping Li ,&nbsp;Weiru Liang ,&nbsp;Huihui Fan ,&nbsp;Kang Zhou ,&nbsp;Yuan Li ,&nbsp;Wenrui Yang ,&nbsp;Liping Jing ,&nbsp;Li Zhang ,&nbsp;Lei Ye ,&nbsp;Youzhen Xiong ,&nbsp;Guangxin Peng ,&nbsp;Yang Yang ,&nbsp;Weiping Yuan ,&nbsp;Jun Shi ,&nbsp;Fengkui Zhang ,&nbsp;Xin Zhao","doi":"10.1016/j.exphem.2024.104670","DOIUrl":"10.1016/j.exphem.2024.104670","url":null,"abstract":"<div><div>Severe aplastic anemia (SAA) is a life-threatening bone marrow failure disease. The addition of eltrombopag to immunosuppressive therapy (IST) improves the response rate, but its hepatotoxicity is concerning. Avatrombopag (AVA), a small-molecule thrombopoietin-receptor agonist without hepatotoxicity, has unknown efficacy in SAA treatment. This retrospective study assessed the efficacy and safety of AVA added to IST 42 SAA patients compared to a historical cohort of 84 patients receiving IST alone, using propensity score matching. The median age was 31.5 (6.0–67.0 years) years old in group A and 26 (16.0–45.0 years) years old in group B. At 3 months, group A showed higher complete response (CR) and overall response (OR) rates than group B (CR: 19.0% vs. 4.8%, <em>p</em> = 0.024; OR: 54.8% vs. 39.3%, <em>p</em> = 0.145). Higher CR and OR rates were also found at 6 months in group A than in group B (CR: 31.0% vs. 14.3%, <em>p</em> = 0.145; OR 71.4% vs. 51.2%, <em>p</em> = 0.048). In multivariate analysis of group A, a shorter interval from disease onset to antithymocyte globulin (ATG) treatment (≤6 months) (<em>p</em> = 0.005) predicted better responses rate at 6 months. Event-free survival was also improved in group A (60.7% vs. 49.6%). AVA was well-tolerated, with no hepatic injury observed during treatment, even in those with pre-existing hepatic impairment. The addition of AVA to IST improves both the response rate and response quality in patients with SAA while ensuring safety.</div></div>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":"140 ","pages":"Article 104670"},"PeriodicalIF":2.5,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142589453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ever-evolving insights into the cellular and molecular drivers of lymphoid cell development 对淋巴细胞发育的细胞和分子驱动因素的认识不断发展。
IF 2.5 4区 医学 Q2 HEMATOLOGY Pub Date : 2024-10-23 DOI: 10.1016/j.exphem.2024.104667
Vu L. Tran , Myriam L.R. Haltalli , Jingjing Li , Dawn S. Lin , Masayuki Yamashita , Shalin H. Naik , Ellen V. Rothenberg
Lymphocytes play a critical role in adaptive immunity and defense mechanisms, but the molecular mechanisms by which hematopoietic stem and progenitor cells differentiate into T and B lymphocytes are not fully established. Pioneer studies identify several transcription factors essential for lymphoid lineage determination. Yet, many questions remain unanswered about how these transcription factors interact with each other and with chromatin at different developmental stages. This interaction regulates a network of genes and proteins, promoting lymphoid lineage differentiation while suppressing other lineages. Throughout this intricate biological process, any genetic or epigenetic interruptions can derail normal differentiation trajectories, potentially leading to various human pathologic conditions. Here, we summarize recent advances in understanding lymphoid cell development, which was the focus of the Winter 2024 International Society for Experimental Hematology webinar.
淋巴细胞在适应性免疫和防御机制中发挥着关键作用,但造血干细胞和祖细胞分化成 T 淋巴细胞和 B 淋巴细胞的分子机制尚未完全确定。先驱研究发现了几种对淋巴细胞系决定至关重要的转录因子。然而,关于这些转录因子在不同发育阶段如何相互影响以及如何与染色质相互作用,许多问题仍未得到解答。这种相互作用调节着基因和蛋白质网络,在促进淋巴系分化的同时抑制其他系的分化。在这一错综复杂的生物过程中,任何遗传或表观遗传干扰都可能破坏正常的分化轨迹,从而可能导致各种人类病症。在此,我们总结了了解淋巴细胞发育的最新进展,这也是 2024 年冬季国际实验血液学会网络研讨会的重点。
{"title":"Ever-evolving insights into the cellular and molecular drivers of lymphoid cell development","authors":"Vu L. Tran ,&nbsp;Myriam L.R. Haltalli ,&nbsp;Jingjing Li ,&nbsp;Dawn S. Lin ,&nbsp;Masayuki Yamashita ,&nbsp;Shalin H. Naik ,&nbsp;Ellen V. Rothenberg","doi":"10.1016/j.exphem.2024.104667","DOIUrl":"10.1016/j.exphem.2024.104667","url":null,"abstract":"<div><div>Lymphocytes play a critical role in adaptive immunity and defense mechanisms, but the molecular mechanisms by which hematopoietic stem and progenitor cells differentiate into T and B lymphocytes are not fully established. Pioneer studies identify several transcription factors essential for lymphoid lineage determination. Yet, many questions remain unanswered about how these transcription factors interact with each other and with chromatin at different developmental stages. This interaction regulates a network of genes and proteins, promoting lymphoid lineage differentiation while suppressing other lineages. Throughout this intricate biological process, any genetic or epigenetic interruptions can derail normal differentiation trajectories, potentially leading to various human pathologic conditions. Here, we summarize recent advances in understanding lymphoid cell development, which was the focus of the Winter 2024 International Society for Experimental Hematology webinar.</div></div>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":"140 ","pages":"Article 104667"},"PeriodicalIF":2.5,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142497731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Splicing the Difference: Harnessing the Complexity of the Transcriptome in Hematopoiesis 剪接差异:利用造血过程中转录组的复杂性。
IF 2.5 4区 医学 Q2 HEMATOLOGY Pub Date : 2024-10-10 DOI: 10.1016/j.exphem.2024.104655
Hannah M. Maul-Newby, Stephanie Halene
Alternative splicing has long been recognized as a powerful tool to expand the diversity of the transcriptome and the proteome. The study of hematopoiesis, from hematopoietic stem cell maintenance and differentiation into committed progenitors to maturation into functional blood cells, has led the field of stem cell research and cellular differentiation for decades. The importance of aberrant splicing due to mutations in cis has been exemplified in thalassemias, resulting from aberrant expression of β-globin. The simultaneous development of increasingly sophisticated technologies, in particular the combination of multicolor flow cytometric cell sorting with bulk and single-cell sequencing, has provided sophisticated insights into the complex regulation of the blood system. The recognition that mutations in key splicing factors drive myeloid malignancies, in particular myelodysplastic syndromes, has galvanized research into alternative splicing in hematopoiesis and its diseases.
In this review, we will update the audience on the exciting novel technologies, highlight alternative splicing events and their regulators with essential functions in hematopoiesis, and provide a high-level overview how splicing factor mutations contribute to hematologic malignancies.
长期以来,人们一直认为替代剪接是扩大转录组和蛋白质组多样性的有力工具。对造血的研究,从造血干细胞的维持、分化为有责任感的祖细胞到成熟为功能性血细胞,几十年来一直引领着干细胞研究和细胞分化领域。在地中海贫血症中,由于β-球蛋白的异常表达,顺式突变导致的异常剪接非常重要。与此同时,越来越先进的技术,特别是多色流式细胞分选技术与大量和单细胞测序技术的结合,使人们对血液系统的复杂调控有了更深入的了解。人们认识到,关键剪接因子的突变会导致骨髓恶性肿瘤,尤其是骨髓增生异常综合征,这激发了对造血及其疾病中替代剪接的研究。在这篇综述中,我们将向听众介绍令人兴奋的新技术的最新进展,重点介绍在造血过程中具有重要功能的替代剪接事件及其调控因子,并高度概括剪接因子突变是如何导致血液系统恶性肿瘤的。
{"title":"Splicing the Difference: Harnessing the Complexity of the Transcriptome in Hematopoiesis","authors":"Hannah M. Maul-Newby,&nbsp;Stephanie Halene","doi":"10.1016/j.exphem.2024.104655","DOIUrl":"10.1016/j.exphem.2024.104655","url":null,"abstract":"<div><div>Alternative splicing has long been recognized as a powerful tool to expand the diversity of the transcriptome and the proteome. The study of hematopoiesis, from hematopoietic stem cell maintenance and differentiation into committed progenitors to maturation into functional blood cells, has led the field of stem cell research and cellular differentiation for decades. The importance of aberrant splicing due to mutations in <em>cis</em> has been exemplified in thalassemias, resulting from aberrant expression of β-globin. The simultaneous development of increasingly sophisticated technologies, in particular the combination of multicolor flow cytometric cell sorting with bulk and single-cell sequencing, has provided sophisticated insights into the complex regulation of the blood system. The recognition that mutations in key splicing factors drive myeloid malignancies, in particular myelodysplastic syndromes, has galvanized research into alternative splicing in hematopoiesis and its diseases.</div><div>In this review, we will update the audience on the exciting novel technologies, highlight alternative splicing events and their regulators with essential functions in hematopoiesis, and provide a high-level overview how splicing factor mutations contribute to hematologic malignancies.</div></div>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":"140 ","pages":"Article 104655"},"PeriodicalIF":2.5,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142406302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microenvironment in acute myeloid leukemia: focus on senescence mechanisms, therapeutic interactions, and future directions 急性髓细胞白血病的微环境:关注衰老机制、治疗相互作用和未来方向。
IF 2.6 4区 医学 Q2 HEMATOLOGY Pub Date : 2024-01-01 DOI: 10.1016/j.exphem.2023.09.005
Luca Guarnera , Enrico Santinelli , Elisa Galossi , Antonio Cristiano , Emiliano Fabiani , Giulia Falconi , Maria Teresa Voso

Acute myeloid leukemia (AML) is a disease with a dismal prognosis, mainly affecting the elderly. In recent years, new drugs have improved life expectancy and quality of life, and a better understanding of the genetic-molecular nature of the disease has shed light on previously unknown aspects of leukemogenesis.

In parallel, increasing attention has been attracted to the complex interactions between cells and soluble factors in the bone marrow (BM) environment, collectively known as the microenvironment.

In this review, we discuss the central role of the microenvironment in physiologic and pathologic hematopoiesis and the mechanisms of senescence, considered a fundamental protective mechanism against the proliferation of damaged and pretumoral cells. The microenvironment also represents a fertile ground for the development of myeloid malignancies, and the leukemic niche significantly interacts with drugs commonly used in AML treatment. Finally, we focus on the role of the microenvironment in the engraftment and complications of allogeneic hematopoietic stem cell transplantation, the only curative option in a conspicuous proportion of patients.

急性髓细胞白血病(AML)是一种预后不佳的疾病,主要影响老年人。近年来,新药提高了预期寿命和生活质量,对该疾病的遗传分子性质的更好理解揭示了以前未知的白血病发生方面。与此同时,人们越来越关注骨髓环境中细胞和可溶性因子之间的复杂相互作用,统称为微环境。在这篇综述中,我们讨论了微环境在生理和病理造血中的核心作用以及衰老的机制,认为衰老是对抗受损和肿瘤前细胞增殖的基本保护机制。微环境也是骨髓恶性肿瘤发展的沃土,白血病小生境与AML治疗中常用的药物显著相互作用。最后,我们重点研究了微环境在异基因造血干细胞移植的植入和并发症中的作用,这是相当大比例患者的唯一治疗选择。
{"title":"Microenvironment in acute myeloid leukemia: focus on senescence mechanisms, therapeutic interactions, and future directions","authors":"Luca Guarnera ,&nbsp;Enrico Santinelli ,&nbsp;Elisa Galossi ,&nbsp;Antonio Cristiano ,&nbsp;Emiliano Fabiani ,&nbsp;Giulia Falconi ,&nbsp;Maria Teresa Voso","doi":"10.1016/j.exphem.2023.09.005","DOIUrl":"10.1016/j.exphem.2023.09.005","url":null,"abstract":"<div><p>Acute myeloid leukemia (AML) is a disease with a dismal prognosis, mainly affecting the elderly. In recent years, new drugs have improved life expectancy and quality of life, and a better understanding of the genetic-molecular nature of the disease has shed light on previously unknown aspects of leukemogenesis.</p><p>In parallel, increasing attention has been attracted to the complex interactions between cells and soluble factors in the bone marrow (BM) environment, collectively known as the microenvironment.</p><p>In this review, we discuss the central role of the microenvironment in physiologic and pathologic hematopoiesis and the mechanisms of senescence, considered a fundamental protective mechanism against the proliferation of damaged and pretumoral cells. The microenvironment also represents a fertile ground for the development of myeloid malignancies, and the leukemic niche significantly interacts with drugs commonly used in AML treatment. Finally, we focus on the role of the microenvironment in the engraftment and complications of allogeneic hematopoietic stem cell transplantation, the only curative option in a conspicuous proportion of patients.</p></div>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":"129 ","pages":"Article 104118"},"PeriodicalIF":2.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0301472X23017058/pdfft?md5=01d45253098251d7824d4d8b8d687693&pid=1-s2.0-S0301472X23017058-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41106676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MiR-223-3p promotes genomic stability of hematopoietic progenitors after radiation MiR223-3p促进放射后造血祖细胞基因组稳定性
IF 2.6 4区 医学 Q2 HEMATOLOGY Pub Date : 2024-01-01 DOI: 10.1016/j.exphem.2023.10.002
Shi Chen , Gayathri Srinivasan , Aruna Jaiswal , Elizabeth A. Williamson , Lingxiao Li , Dominic Arris , Daohong Zhou , Mingjiang Xu , Robert Hromas

When hematopoietic cells are overwhelmed with ionizing radiation (IR) DNA damage, the alternative non-homologous end-joining (aNHEJ) repair pathway is activated to repair stressed replication forks. While aNHEJ can rescue cells overwhelmed with DNA damage, it can also mediate chromosomal deletions and fusions, which can cause mis-segregation in mitosis and resultant aneuploidy. We previously reported that a hematopoietic microRNA, miR-223-3p, normally represses aNHEJ. We found that miR-223−/− mice have increased survival of hematopoietic stem and progenitor cells (HSPCs) after sublethal IR. However, this came at the cost of significantly more genomic aberrancies, with miR-223−/− hematopoietic progenitors having increased metaphase aberrancies, including chromothripsis, and increased sequence abnormalities, especially deletions, which is consistent with aNHEJ. These data imply that when an HSPC is faced with substantial DNA damage, it may trade genomic damage for its own survival by choosing the aNHEJ repair pathway, and this choice is regulated in part by miR-223-3p.

当造血细胞被电离辐射(IR)DNA损伤淹没时,替代性非同源末端连接(aNHEJ)修复途径被激活以修复应激复制叉。虽然aNHEJ可以拯救被DNA损伤淹没的细胞,但它也可以介导染色体缺失和融合,这可能导致有丝分裂中的错误分离,并导致非整倍体。我们之前报道了一种造血微小RNA,miR223-3p,通常抑制aNEJ。我们发现,miR223-/-小鼠在亚致死性IR后提高了造血干细胞和祖细胞(HSPC)的存活率。然而,这是以显著更多的基因组变异为代价的,miR223/-造血祖细胞具有增加的中期变异,包括染色体畸变,以及增加的序列异常,尤其是缺失,这与aNEJ一致。这些数据表明,当HSPC面临严重的DNA损伤时,它可能会通过选择aNEJ修复途径来换取基因组损伤,而这种选择在一定程度上受到miR223-3p的调节。
{"title":"MiR-223-3p promotes genomic stability of hematopoietic progenitors after radiation","authors":"Shi Chen ,&nbsp;Gayathri Srinivasan ,&nbsp;Aruna Jaiswal ,&nbsp;Elizabeth A. Williamson ,&nbsp;Lingxiao Li ,&nbsp;Dominic Arris ,&nbsp;Daohong Zhou ,&nbsp;Mingjiang Xu ,&nbsp;Robert Hromas","doi":"10.1016/j.exphem.2023.10.002","DOIUrl":"10.1016/j.exphem.2023.10.002","url":null,"abstract":"<div><p>When hematopoietic cells are overwhelmed with ionizing radiation (IR) DNA damage, the alternative non-homologous end-joining (aNHEJ) repair pathway is activated to repair stressed replication forks. While aNHEJ can rescue cells overwhelmed with DNA damage, it can also mediate chromosomal deletions and fusions, which can cause mis-segregation in mitosis and resultant aneuploidy. We previously reported that a hematopoietic microRNA, miR-223-3p, normally represses aNHEJ. We found that miR-223<sup>−/−</sup> mice have increased survival of hematopoietic stem and progenitor cells (HSPCs) after sublethal IR. However, this came at the cost of significantly more genomic aberrancies, with miR-223<sup>−/−</sup> hematopoietic progenitors having increased metaphase aberrancies, including chromothripsis, and increased sequence abnormalities, especially deletions, which is consistent with aNHEJ. These data imply that when an HSPC is faced with substantial DNA damage, it may trade genomic damage for its own survival by choosing the aNHEJ repair pathway, and this choice is regulated in part by miR-223-3p.</p></div>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":"129 ","pages":"Article 104123"},"PeriodicalIF":2.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0301472X2301737X/pdfft?md5=afb05969a5e4bb740dd86dc3ec469d7c&pid=1-s2.0-S0301472X2301737X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50157376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How nutrition regulates hematopoietic stem cell features 营养如何调节造血干细胞特征。
IF 2.6 4区 医学 Q2 HEMATOLOGY Pub Date : 2023-12-01 DOI: 10.1016/j.exphem.2023.09.008
Katharina Schönberger, Nina Cabezas-Wallscheid

Our dietary choices significantly impact all the cells in our body. Increasing evidence suggests that diet-derived metabolites influence hematopoietic stem cell (HSC) metabolism and function, thereby actively modulating blood homeostasis. This is of particular relevance because regulating the metabolic activity of HSCs is crucial for maintaining stem cell fitness and mitigating the risk of hematologic disorders. In this review, we examine the current scientific knowledge of the impact of diet on stemness features, and we specifically highlight the established mechanisms by which dietary components modulate metabolic and transcriptional programs in adult HSCs. Gaining a deeper understanding of how nutrition influences our HSC compartment may pave the way for targeted dietary interventions with the potential to decelerate aging and improve the effectiveness of transplantation and cancer therapies.

我们的饮食选择会显著影响我们身体中的所有细胞。越来越多的证据表明,饮食衍生的代谢产物影响造血干细胞(HSC)的代谢和功能,从而积极调节血液稳态。这是特别相关的,因为调节HSC的代谢活性对于维持干细胞健康和降低血液系统疾病的风险至关重要。在这篇综述中,我们研究了目前关于饮食对干性特征影响的科学知识,并特别强调了饮食成分调节成年HSC代谢和转录程序的既定机制。更深入地了解营养如何影响我们的HSC室,可能会为有针对性的饮食干预铺平道路,这些干预有可能减缓衰老并提高移植和癌症治疗的有效性。
{"title":"How nutrition regulates hematopoietic stem cell features","authors":"Katharina Schönberger,&nbsp;Nina Cabezas-Wallscheid","doi":"10.1016/j.exphem.2023.09.008","DOIUrl":"10.1016/j.exphem.2023.09.008","url":null,"abstract":"<div><p>Our dietary choices significantly impact all the cells in our body. Increasing evidence suggests that diet-derived metabolites influence hematopoietic stem cell (HSC) metabolism and function, thereby actively modulating blood homeostasis. This is of particular relevance because regulating the metabolic activity of HSCs is crucial for maintaining stem cell fitness and mitigating the risk of hematologic disorders. In this review, we examine the current scientific knowledge of the impact of diet on stemness features, and we specifically highlight the established mechanisms by which dietary components modulate metabolic and transcriptional programs in adult HSCs. Gaining a deeper understanding of how nutrition influences our HSC compartment may pave the way for targeted dietary interventions with the potential to decelerate aging and improve the effectiveness of transplantation and cancer therapies.</p></div>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":"128 ","pages":"Pages 10-18"},"PeriodicalIF":2.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0301472X23017356/pdfft?md5=a01b2622fa3f9a2190295e5aa97873d5&pid=1-s2.0-S0301472X23017356-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41195978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The multifaceted role of mitochondria in HSC fate decisions: energy and beyond 线粒体在HSC命运决定中的多方面作用:能量和超越。
IF 2.6 4区 医学 Q2 HEMATOLOGY Pub Date : 2023-12-01 DOI: 10.1016/j.exphem.2023.10.001
Marie-Dominique Filippi

Hematopoietic stem cells (HSCs) have the properties to self-renew and/or differentiate into all-mature blood cell lineages. The fate decisions to generate progeny that retain stemness properties or that commit to differentiation is a fundamental process to maintain tissue homeostasis and must be tightly regulated to prevent HSC overgrowth or exhaustion. HSC fate decisions are inherently coupled to cell division. The transition from quiescence to activation is accompanied by major metabolic and mitochondrial changes that are important for cell cycle entry and for balanced decisions between self-renewal and differentiation. In this review, we discuss the current understanding of the role of mitochondrial metabolism in HSC transition from quiescence to activation and fate decisions.

造血干细胞具有自我更新和/或分化为所有成熟血细胞谱系的特性。产生保持干性特性或致力于分化的后代的命运决定是维持组织稳态的基本过程,必须严格调节以防止HSC过度生长或衰竭。HSC的命运决定本质上与细胞分裂有关。从静止到激活的转变伴随着主要的代谢和线粒体变化,这些变化对于细胞周期的进入对于自我更新和分化之间的平衡决策很重要。在这篇综述中,我们讨论了目前对线粒体代谢在HSC从静止过渡到激活和命运决定中的作用的理解。
{"title":"The multifaceted role of mitochondria in HSC fate decisions: energy and beyond","authors":"Marie-Dominique Filippi","doi":"10.1016/j.exphem.2023.10.001","DOIUrl":"10.1016/j.exphem.2023.10.001","url":null,"abstract":"<div><p>Hematopoietic stem cells (HSCs) have the properties to self-renew and/or differentiate into all-mature blood cell lineages. The fate decisions to generate progeny that retain stemness properties or that commit to differentiation is a fundamental process to maintain tissue homeostasis and must be tightly regulated to prevent HSC overgrowth or exhaustion. HSC fate decisions are inherently coupled to cell division. The transition from quiescence to activation is accompanied by major metabolic and mitochondrial changes that are important for cell cycle entry and for balanced decisions between self-renewal and differentiation. In this review, we discuss the current understanding of the role of mitochondrial metabolism in HSC transition from quiescence to activation and fate decisions.</p></div>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":"128 ","pages":"Pages 19-29"},"PeriodicalIF":2.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41195979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Experimental hematology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1